Abstract
Objective: to study the major factors that influence treatment adherence. Patients and methods. One hundred patients aged 20 to 68 years (mean age 42.9±3.0 years for women and 43.3±5.0 years for men) diagnosed with a ≥3-year history of symptomatic epilepsy were screened. The minimal and maximal durations of the disease were 5 and 59 years, respectively (mean 20.8±3.9 years). Results and discussion. There was a female preponderance in the treatment adherence group. The patients who had secondary special education were unemployed, disabled, and single were in both comparison groups. These data are indicative of social stigmatization in epileptic patients. Patients with severe epilepsy on multiple drug therapy were prevalent. Neuropsychological testing revealed higher levels of anxiety and depression among those who were non-adherent to therapy. Conclusion. The sex, age, and social characteristics (education level, disability) of patients with epilepsy and its clinical picture, neurological symptoms and changes were ascertained by magnetic resonance imaging had no significant impact on therapy adherence. The factors influencing treatment adherence should include multiple drug therapy (co-administration of two or three drugs) and the high frequency of drug use, which is more frequently observed in patients with severe treatment-resistant epilepsy. Anxiety and depressive disorders in epileptic patients resulted in impaired compliance with anticonvulsant therapy.
Highlights
Цель исследования – изучить основные факторы, оказывающие влияние на приверженность терапии
Neuropsychological testing revealed higher levels of anxiety and depression among those who were non-adherent to therapy
The sex, age, and social characteristics of patients with epilepsy and its clinical picture, neurological symptoms and changes were ascertained by magnetic resonance imaging had no significant impact on therapy adherence
Summary
Вагина М.А.1, Волкова Л.И.2 1ГБУЗ СО «Свердловская областная клиническая больница No1», Екатеринбург, Россия; 2Кафедра нервных болезней и нейрохирургии ГБОУ ВПО «Уральский государственный медицинский университет». Скринингу подвергнуты 100 пациентов с диагнозом симптоматической эпилепсии, давностью болезни ≥3 лет, в возрасте от 20 до 68 лет (средний возраст 42,9±3,0 года у женщин и 43,3±5,0 года у мужчин). Что половозрастные и социальные особенности пациентов с эпилепсией (уровень образования, наличие инвалидности), а также клиническая картина заболевания, неврологическая симптоматика и изменения, выявляемые при проведении магнитно-резонансной томографии, достоверного влияния на приверженность терапии не оказывали. К факторам, оказывающим влияние на приверженность терапии, следует отнести политерапию (прием двух и трех препаратов одновременно) и высокую кратность приема препаратов, что чаще наблюдается у пациентов с тяжелым течением болезни, относительно резистентным к лечению. И вновь увеличивается в пожилом и старческом возрасте, Средний возраст пациентов в группах сравнения был составляя в среднем от 30 до 70 случаев на 100 тыс. По результатам 31,9%), без достоверных различий с группой пациентов, не исследования, проведенного журналом Neurology, у боль- приверженных терапии (р=0,9914). 0,5023 вила 5 лет, максимальная – 59 лет (в среднем 20,8±3,9 года)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
